Information
News News
- News Release
Elix, an AI Drug Discovery Company and University of Vienna Enter into Joint Research Agreement to Advance Drug Discovery Using AI Technology
- Information
Elix will exhibit at the AI-Driven Drug Discovery Forum on July 14
- Information
Our CEO, Shinya, Will Give a Presentation at the Technology Seminar of the 30th Annual Meeting of the Japanese Association for Molecular Target Therapy of Cancer
MedChem’s ultimate partner for AI drug discovery,
from predictive and generative models with an intuitive UI to expert consulting, all in a single package.
Data Advantage:
16 Pharma Partners
AI models trained on proprietary data from 16 pharma partners, covering activity, ADME, and toxicity.
Novel Structures
Beyond Human ImaginationDesigns novel, non-obvious structures, proven across multiple programs.
PhD-Led Consulting & Support
Experienced PhD scientists provide hands-on onboarding, workflow integration, and ongoing support.
Partners
Our Clients and Partners
We are collaborating with pharmaceutical companies, academic institutes, and drug discovery start-ups.
